Beijing New Oriental Star Petrochemical Engineering Co Ltd (002755) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Beijing New Oriental Star Petrochemical Engineering Co Ltd (002755) has a cash flow conversion efficiency ratio of 0.057x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥187.71 Million ≈ $27.47 Million USD) by net assets (CN¥3.27 Billion ≈ $478.73 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Beijing New Oriental Star Petrochemical liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Beijing New Oriental Star Petrochemical Engineering Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how Beijing New Oriental Star Petrochemical Engineering Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Beijing New Oriental Star Petrochemical Engineering Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Beijing New Oriental Star Petrochemical Engineering Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Photronics Inc
NASDAQ:PLAB
|
0.028x |
|
Dno ASA
OL:DNO
|
0.225x |
|
4iG Nyrt.
BUD:4IG
|
0.147x |
|
Live Oak Bancshares, Inc.
NYSE:LOB
|
0.068x |
|
Ruentex Engineering & Construction Co Ltd
TW:2597
|
-0.059x |
|
JiLin Sino-Microelectronics Co Ltd
SHG:600360
|
0.476x |
|
Vishay Intertechnology Inc
NYSE:VSH
|
0.013x |
|
Hunan Zhongke Electric
SHE:300035
|
-0.089x |
Annual Cash Flow Conversion Efficiency for Beijing New Oriental Star Petrochemical Engineering Co Ltd (2011–2024)
The table below shows the annual cash flow conversion efficiency of Beijing New Oriental Star Petrochemical Engineering Co Ltd from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see 002755 stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥3.14 Billion ≈ $459.81 Million |
CN¥411.36 Million ≈ $60.19 Million |
0.131x | +1583.47% |
| 2023-12-31 | CN¥3.01 Billion ≈ $440.56 Million |
CN¥-26.57 Million ≈ $-3.89 Million |
-0.009x | +49.65% |
| 2022-12-31 | CN¥3.01 Billion ≈ $440.95 Million |
CN¥-52.81 Million ≈ $-7.73 Million |
-0.018x | -109.96% |
| 2021-12-31 | CN¥3.23 Billion ≈ $472.29 Million |
CN¥567.71 Million ≈ $83.07 Million |
0.176x | -8.07% |
| 2020-12-31 | CN¥3.03 Billion ≈ $443.85 Million |
CN¥580.38 Million ≈ $84.93 Million |
0.191x | -9.93% |
| 2019-12-31 | CN¥2.52 Billion ≈ $368.25 Million |
CN¥534.62 Million ≈ $78.23 Million |
0.212x | -21.33% |
| 2018-12-31 | CN¥1.84 Billion ≈ $269.39 Million |
CN¥497.16 Million ≈ $72.75 Million |
0.270x | +414.08% |
| 2017-12-31 | CN¥585.03 Million ≈ $85.61 Million |
CN¥-50.30 Million ≈ $-7.36 Million |
-0.086x | -361.81% |
| 2016-12-31 | CN¥509.40 Million ≈ $74.54 Million |
CN¥16.73 Million ≈ $2.45 Million |
0.033x | +2179.89% |
| 2015-12-31 | CN¥508.35 Million ≈ $74.39 Million |
CN¥-802.68K ≈ $-117.46K |
-0.002x | +98.51% |
| 2014-12-31 | CN¥333.61 Million ≈ $48.82 Million |
CN¥-35.30 Million ≈ $-5.17 Million |
-0.106x | -143.79% |
| 2013-12-31 | CN¥307.51 Million ≈ $45.00 Million |
CN¥-13.35 Million ≈ $-1.95 Million |
-0.043x | -110.74% |
| 2012-12-31 | CN¥263.39 Million ≈ $38.54 Million |
CN¥106.47 Million ≈ $15.58 Million |
0.404x | +160.84% |
| 2011-12-31 | CN¥214.83 Million ≈ $31.44 Million |
CN¥33.29 Million ≈ $4.87 Million |
0.155x | -- |
About Beijing New Oriental Star Petrochemical Engineering Co Ltd
Beijing Aosaikang Pharmaceutical Co., Ltd. researches, develops, manufactures, markets, and sells pharmaceuticals, fine chemicals, and health-care products in China. It offers proton pump inhibitor injections and oncology medicines, as well as APIs. The company provides its products in oncology, antibiotic, and other areas. Beijing Aosaikang Pharmaceutical Co., Ltd. was founded in 2003 and is bas… Read more